BIO is a curation and liquidity protocol specifically designed for Decentralized Science (DeSci). Its primary goal is to enhance the biotechnology sector by empowering global communities of patients, scientists, and biotech professionals to collaboratively fund, develop, and own tokenized biotech projects and intellectual property. The team behind BIO has significant experience in the field, having previously contributed to the creation of Molecule, a platform focused on the tokenization of early-stage biomedicine, and VitaDAO, which stands as the largest decentralized community for longevity science. Building on these foundational successes, BIO aims to foster an on-chain scientific economy through decentralized funding mechanisms, incentives, and increased liquidity. Holders of the BIO token gain access to a diverse network of scientific communities and intellectual property within the DeSci landscape. This access provides users with extensive exposure to the evolving DeSci economy, promoting engagement and collaboration among stakeholders. By facilitating a decentralized approach to biotechnology funding and project development, BIO stands to drive innovation and advancements in the life sciences sector. Through its unique ecosystem, BIO seeks to create sustainable growth and impactful outcomes in biotechnology.